Recent evidence suggests that psychedelics can induce rapid and long-lasting antidepressant effects. The generally acknowledged explanation for these traits is the phenomenon of neuroplasticity, although the exact underlying molecular mechanisms remain unclear.
Aims:
This study investigates the effects of psilocin, lysergic acid diethylamide (LSD) and N,N-dimethyltryptamine (DMT) on synaptogenesis and immediate early genes (IEGs) expression in direct comparison with ketamine, fluoxetine and lithium after acute (1 h) and/or prolonged (24 h) treatment in vitro.
Methods:
Rat primary cortical cultures were treated with 10 µM psilocin, 1 µM LSD, 90 µM DMT, 1 µM ketamine, 10 µM fluoxetine and 5 mM lithium. Analysis of synaptic puncta was performed; puncta of presynaptic marker synapsin I/II, postsynaptic density protein 95 (PSD-95) and their co-localization (established synapse) were assessed 24 h after drug treatment. Next, expressions of IEGs encoding activity-regulated cytoskeleton-associated protein (Arc), early growth response 1 (Egr1), and neuronal PAS (Per-Arnt-Sim) domain protein 4 (Npas4) were analysed 1 and 24 h after drug treatments.
Results:
Psilocin increased synaptic puncta count and induced Arc expression. The effect to promote synaptogenesis was comparable to ketamine and lithium; ketamine additionally increased PSD-95 puncta count. LSD and DMT did not induce any significant effects. Interestingly, fluoxetine had no effect on synaptic puncta count, but upregulated Egr1 and Npas4.
Conclusions:
Psilocin demonstrated synaptogenic effects comparable to those of ketamine and lithium, and acutely upregulated IEG Arc expression, adding another piece of evidence to its profile as a promising therapeutic agent.
AdamsKWKletsovSLammRJ, et al. (2017) Role for egr1 in the transcriptional program associated with neuronal differentiation of pc12 cells. PLoS ONE12(1). https://doi.org/10.1371/journal.pone.0170076
2.
AndersenCLJensenJLFalck ØrntoftT (2004) Normalization of Real-Time Quantitative Reverse Transcription-PCR Data: A Model-Based Variance Estimation Approach to Identify Genes Suited for Normalization, Applied to Bladder and Colon Cancer Data Sets. In CANCER RESEARCH (Vol. 64). http://www.ncbi.nlm.nih.gov/RefSeq/
3.
AntoniadouIKouskouMArsiwalaT, et al. (2018) Ebselen has lithium-like effects on central 5-HT 2A receptor function. Br J Pharmacol175: 2599–2610.
4.
BaroneIMelaniRMainardiM, et al. (2018) Fluoxetine modulates the activity of hypothalamic POMC neurons via mTOR signaling. Mol Neurobiol55: 9267–9279.
5.
CameronLPBenetatosJLewisV, et al. (2023) Beyond the 5-HT2A receptor: Classic and nonclassic targets in psychedelic drug action. J Neurosci43: 7472–7482.
6.
CameronLPBensonCJDefeliceBC, et al. (2019) Chronic, intermittent microdoses of the psychedelic N, N-dimethyltryptamine (DMT) produce positive effects on mood and anxiety in rodents. ACS Chem Neurosci10: 3261–3270.
7.
Carhart-HarrisRLGoodwinGM (2017) The therapeutic potential of psychedelic drugs: Past, present, and future. Neuropsychopharmacology42: 2105–2113.
8.
CasarottoPCGirychMFredSM, et al. (2021). Antidepressant drugs act by directly binding to TRKB neurotrophin receptors. Cell184: 1299–1313.e19.
9.
CasarottoPUmemoriJCastrénE (2022) BDNF receptor TrkB as the mediator of the antidepressant drug action. Front Mol Neurosci15: 1032224.
10.
DavoudianPAShaoLXKwanAC (2023) Shared and distinct brain regions targeted for immediate early gene expression by ketamine and psilocybin. ACS Chem Neurosci14: 468–480.
11.
de la Fuente RevengaMZhuBGuevaraCA, et al. (2021) Prolonged epigenomic and synaptic plasticity alterations following single exposure to a psychedelic in mice. Cell Rep37: 109836.
12.
DesouzaLABenekareddyMFanibundaSE, et al. (2021) The hallucinogenic serotonin2A receptor agonist, 2,5-dimethoxy-4-iodoamphetamine, promotes cAMP response element binding protein-dependent gene expression of specific plasticity-associated genes in the rodent neocortex. Front Mol Neurosci14: 790213.
13.
DinizBSMachado-VieiraRForlenzaOV (2013) Lithium and neuroprotection: Translational evidence and implications for the treatment of neuropsychiatric disorders. Neuropsychiatr Dis Treat9: 493–500.
14.
DuYLiYZhaoX, et al. (2023) Psilocybin facilitates fear extinction in mice by promoting hippocampal neuroplasticity. Chin Med J136: 2983–2992.
15.
DzyubenkoERozenbergAHermannDM, et al. (2016) Colocalization of synapse marker proteins evaluated by STED-microscopy reveals patterns of neuronal synapse distribution in vitro. J Neurosci Methods273: 149–159
16.
GitlinM (2016) Lithium side effects and toxicity: Prevalence and management strategies. Int J Bipolar Disord4: 27.
17.
González-MaesoJWeisstaubNVZhouM, et al. (2007) Hallucinogens recruit specific cortical 5-HT 2A receptor-mediated signaling pathways to affect behavior. Neuron53: 439–452.
18.
González-MaesoJYuenTEbersoleBJ, et al. (2003) Cellular/molecular transcriptome fingerprints distinguish hallucinogenic and nonhallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in mouse somatosensory cortex. J Neurosci23: 8836–8843.
19.
GrayJDMcewenBS (2013) Lithium’s role in neural plasticity and its implications for mood disorders. Acta Psychiatr Scand128: 347–361.
20.
HammondsMDShimSS (2009) Effects of 4-week treatment with lithium and olanzapine on levels of brain-derived neurotrophic factor, B-Cell CLL/Lymphoma 2 and phosphorylated cyclic adenosine monophosphate response element-binding protein in the sub-regions of the hippocampus. Basic Clin Pharmacol Toxicol105: 113–119.
21.
HerouxN. A.OsborneB. F.MillerL. A.KawanM.BubanK. N.RosenJ. B.StantonM. E. (2018). Differential expression of the immediate early genes c-Fos, Arc, Egr-1, and Npas4 during long-term memory formation in the context preexposure facilitation effect (CPFE). Neurobiology of Learning and Memory, 147(August 2017), 128–138. https://doi.org/10.1016/j.nlm.2017.11.016
22.
JefsenOHElfvingBWegenerG, et al. (2021) Transcriptional regulation in the rat prefrontal cortex and hippocampus after a single administration of psilocybin. J Psychopharmacol35: 483–493.
23.
JohnsonMWRichardsWAGriffithsRR (2008) Human hallucinogen research: Guidelines for safety. J Psychopharmacol22: 603–620.
24.
JorrattPRicnyJLeiboldC, et al. (2023) Endogenous modulators of NMDA receptor control dendritic field expansion of cortical neurons. Mol Neurobiol60: 1440–1452.
25.
KrystalJHAbdallahCGSanacoraG, et al. (2019) Ketamine: A paradigm shift for depression research and treatment. Neuron101: 774–778.
26.
LererEBotvinnikAShaharO, et al. (2024) Effects of psilocybin, psychedelic mushroom extract and 5-hydroxytryptophan on brain immediate early gene expression: Interaction with serotonergic receptor modulators. Front Pharmacol15: 1391412.
27.
LevyMJFBoulleFEmeritMB, et al. (2019) 5-HTT independent effects of fluoxetine on neuroplasticity. Scient Rep9: 6311.
28.
LiHAksenovaMBertrandSJ, et al. (2016) Quantification of filamentous actin (F-actin) puncta in rat cortical neurons. J Visual Exp2016: e53697.
29.
LiLCarterJGaoX, et al. (2005) The neuroplasticity-associated Arc gene is a direct transcriptional target of early growth response (Egr) transcription factors. Mol Cell Bio25: 10286–10300.
30.
LiNLeeBLiuRJ, et al. (2010) mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Sci329: 959–964.
31.
LinYBloodgoodBLHauserJL, et al. (2008) Activity-dependent regulation of inhibitory synapse development by Npas4. Nature455: 1198–1204.
32.
LiuJWangYXiaK, et al. (2023) Acute psilocybin increased cortical activities in rats. Front Neurosci17: 1168911.
33.
LivakKJSchmittgenTD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods25: 402–408.
34.
LuJTjiaMMullenB, et al. (2021) An analog of psychedelics restores functional neural circuits disrupted by unpredictable stress. Mol Psychiatry26: 6237–6252.
35.
LyCGrebACCameronLP, et al. (2018) Psychedelics promote structural and functional neural plasticity. Cell Rep23: 3170–3182.
36.
LyCGrebACVargasMV, et al. (2021) Transient stimulation with psychoplastogens is sufficient to initiate neuronal growth. ACS Pharmacol Trans Sci4: 452–460.
37.
MartinDANicholsCD (2016) Psychedelics recruit multiple cellular types and produce complex transcriptional responses within the brain. EBioMedicine11: 262–277.
38.
Maya VetencourtJFSaleAViegiA, et al. (2008) The antidepressant fluoxetine restores plasticity in the adult visual cortex. Science320: 385–388.
39.
Moda-SavaRNMurdockMHParekhPK, et al. (2019) Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation. Science364: eaat8078.
40.
MolinerRGirychMBrunelloCA, et al. (2023) Psychedelics promote plasticity by directly binding to BDNF receptor TrkB. Nat Neurosci26: 1032–1041.
41.
NardouRSawyerESongYJ, et al. (2023) Psychedelics reopen the social reward learning critical period. Nature618: 790–798.
42.
NicholasCRHenriquezKMGassmanMC, et al. (2018) High dose psilocybin is associated with positive subjective effects in healthy volunteers. J Psychopharmacol32: 770–778.
43.
NicholsCDSanders-BushE (2002) A single dose of lysergic acid diethylamide influences gene expression patterns within the mammalian brain. Neuropsychopharmacology26: 634–642.
44.
NogueiraMFerreira GolbertDCMenezesR, et al. (2024) Serotonergic psychedelic 5-MeO-DMT alters plasticity-related gene expression and generates anxiolytic effects in stressed mice. Mol Psychiatry30: 50–60.
45.
OkunoHMinatoharaKBitoH (2018) Inverse synaptic tagging: An inactive synapse-specific mechanism to capture activity-induced Arc/arg3.1 and to locally regulate spatial distribution of synaptic weights. Semin Cell Dev Biol77: 43–50.
46.
PeiQLewisLSprakesME, et al. (2000) Serotonergic regulation of mRNA expression of Arc, an immediate early gene selectively localized at neuronal dendrites. Neuropharmacology39: 463–470.
47.
PhoumthipphavongVBarthasFHassettS, et al. (2016) Longitudinal effects of ketamine on dendritic architecture in vivo in the mouse medial frontal cortex. ENeuro3: 91–95.
48.
Puglisi-AllegraSRuggieriSFornaiF (2021) Translational evidence for lithium-induced brain plasticity and neuroprotection in the treatment of neuropsychiatric disorders. Trans Psychiatry11: 366.
49.
QinXJiangYTseYC, et al. (2015) Early growth response 1 (Egr-1) regulates N-methyl-daspartate receptor (NMDAR)-dependent transcription of PSD-95 and α-Amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPAR) trafficking in hippocampal primary neurons. J Biol Chem290: 29603–29616.
50.
RădulescuIDrăgoiATrifuS, et al. (2021) Neuroplasticity and depression: Rewiring the brain’s networks through pharmacological therapy (Review). Exp Ther Med22: 1131.
51.
RavalNRJohansenADonovanLL, et al. (2021) A single dose of psilocybin increases synaptic density and decreases 5-HT2A receptor density in the pig brain. Int J Mol Sci22: 1–14.
52.
ReckwegJTvan LeeuwenCJHenquetC, et al. (2023) A phase 1/2 trial to assess safety and efficacy of a vaporized 5-methoxy-N,N-dimethyltryptamine formulation (GH001) in patients with treatment-resistant depression. Front Psychiatry14: 1133414.
53.
Rosas-SánchezGUGermán-PoncianoLJGuillen-RuizG, et al. (2024) Neuroplasticity and mechanisms of action of acute and chronic treatment with antidepressants in preclinical studies. Biomedicines12: 2744.
54.
SchindelinJArganda-CarrerasIFriseE, et al. (2012) Fiji: An open-source platform for biological-image analysis. Nat Methods9: 676–682.
55.
SerafiniG (2012) Neuroplasticity and major depression, the role of modern antidepressant drugs. World J Psychiatry2: 49.
56.
ShaoLXLiaoCGreggI, et al. (2021) Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo. Neuron109: 2535–2544.e4.
57.
SiegelJSPalancaBJAAncesBM, et al. (2021) Prolonged ketamine infusion modulates limbic connectivity and induces sustained remission of treatment-resistant depression. Psychopharmacology238: 1157–1169.
58.
Soeiro-de-SouzaMGDiasVVFigueiraML, et al. (2012) Translating neurotrophic and cellular plasticity: From pathophysiology to improved therapeutics for bipolar disorder. Acta Psychiatr Scand126: 332–341.
UmemoriJWinkelFDidioG, et al. (2018) iPlasticity: Induced juvenile-like plasticity in the adult brain as a mechanism of antidepressants. Psychiatry Clin Neurosci72: 633–653.
61.
VargasMVDunlapLEDongC, et al. (2023) Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors. Science379: 700–706.
62.
VillalbaSGonzálezBJungeS, et al. (2024) 5-HT2A receptor knockout mice show sex-dependent differences following acute noribogaine administration. Int J Mol Sci25: 687.
63.
WinkelFRyazantsevaMVoigtMB, et al. (2021) Pharmacological and optical activation of TrkB in Parvalbumin interneurons regulate intrinsic states to orchestrate cortical plasticity. Mol Psychiatry26: 7247–7256.
64.
WonEKimYK (2017) An oldie but goodie: Lithium in the treatment of bipolar disorder through neuroprotective and neurotrophic mechanisms. Int J Mol Sci18: 2679.
65.
YeJCoulourisGZaretskayaI, et al. (2012) Primer-BLAST: A tool to design target-specific primers for polymerase chain reaction. BMC Bioinformatics13(134). http://www.biomedcentral.com/1471-2105/13/134
66.
ZahraiAVahid-AnsariFDaigleM, et al. (2020) Fluoxetine-induced recovery of serotonin and norepinephrine projections in a mouse model of post-stroke depression. Trans Psychiatry10: 334.
67.
ZhangHBramhamCR (2021) Arc/Arg3.1 function in long-term synaptic plasticity: Emerging mechanisms and unresolved issues. Eur J Neurosci54: 6696–6712.
68.
ZhengWZhouYLLiuWJ, et al. (2018) Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression. J Psychiatr Res106: 61–68.
69.
ZhengWZhouYLLiuWJ, et al. (2019) Neurocognitive performance and repeated-dose intravenous ketamine in major depressive disorder. J Affect Disord246: 241–247.
